Nike’s gloomy forecast puts spotlight on N America slowdown
By Granth Vanaik, Ananya Mariam Rajesh and Katherine Masters (Reuters) -Nike forecast first-quarter revenue below Wall Street expectations on Thursday…
Business
Alkermes wins battle against Sarissa in closely watched boardroom fight
By Svea Herbst-Bayliss NEW YORK (Reuters) -Alkermes beat back activist investor Sarissa Capital Management’s boardroom challenge on Thursday when shareholders…
Goldman Sachs nominates former BofA executive Montag to join board
NEW YORK (Reuters) – Members of Goldman Sachs’ board nominated former Bank of America executive Tom Montag to join as…
Marketmind: China, Japan data bring curtain down on H1
By Jamie McGeever (Reuters) – A look at the day ahead in Asian markets from Jamie McGeever, financial markets columnist….
IMF board completes Ukraine loan review, allowing $890 million withdrawal
By David Lawder and Andrea Shalal WASHINGTON (Reuters) -The International Monetary Fund’s executive board on Thursday completed its first review…
Hold the Ozempic before surgery, US doctors say
By Julie Steenhuysen CHICAGO (Reuters) – People taking popular diabetes and weight loss drugs such as Novo Nordisk’s Ozempic and…
Brazil government sets new 2026 inflation target, tweaks fulfillment time frame
By Victor Borges and Marcela Ayres BRASILIA (Reuters) -Brazil’s National Monetary Council (CMN), the country’s top economic policy body, decided…
Online retailer Overstock rebranding as Bed Bath & Beyond
By Dietrich Knauth NEW YORK (Reuters) -Overstock.com intends to sunset its company name and rebrand as Bed Bath & Beyond…
US FDA approves BioMarin’s gene therapy for hemophilia A
By Nathan Gomes (Reuters) -The U.S. Food and Drug Administration on Thursday approved BioMarin Pharmaceutical’s gene therapy for severe hemophilia…
Volkswagen in talks with Tesla to adopt its charging standard
(Reuters) -Volkswagen is in talks with Tesla to adopt its North American Charging Standard (NACS) technology, while the German automaker’s…